SCHEMBL31268974

SCHEMBL31268974

Cc1ccnc(Cn2c(-c3ccc(OCC(=O)NC(C)C)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ PIK3CD O00329 5/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ CNR1 P21554 2/20 0.32
▸ CNR2 P34972 2/20 0.32
▸ ADAMTS5 Q9UNA0 2/20 0.31
▸ LMNA P02545 2/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ SCN5A Q14524 1/20 0.31
▸ SCN9A Q15858 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31268818 0.93 PIK3CD (0.32) PIK3CD
SCHEMBL31268824 0.92 PIK3CD (0.34) ALDH1A1PIK3CDNPC1RAB9ALMNA
SCHEMBL31269214 0.91 PIK3CD (0.33) PIK3CD
SCHEMBL31269027 0.91 PIK3CD (0.32) PIK3CDNPC1RAB9A
SCHEMBL31269404 0.91 KEAP1 (0.34) ALDH1A1L3MBTL1PIK3CDCNR1CNR2
SCHEMBL31269011 0.90 PIK3CD (0.32) PIK3CD
SCHEMBL31268819 0.90 PIK3CD (0.36) PIK3CDKCNH2SCN5ASCN9A
SCHEMBL31269392 0.90 PIK3CD (0.34) PIK3CDNPC1RAB9AMAPT
SCHEMBL31269166 0.90 ALDH1A1 (0.40) ALDH1A1KDM4EPIK3CDNPC1RAB9A
SCHEMBL31268804 0.90 PIK3CD (0.37) PIK3CDRAB9ACNR1CNR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback